Sales decline 73.56% to Rs 2.44 crore
Net profit of Vivanza Biosciences declined 44.90% to Rs 0.27 crore in the quarter ended June 2024 as against Rs 0.49 crore during the previous quarter ended June 2023. Sales declined 73.56% to Rs 2.44 crore in the quarter ended June 2024 as against Rs 9.23 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var.Sales2.449.23 -74 OPM %14.756.50 -PBDT0.270.49 -45 PBT0.270.49 -45 NP0.270.49 -45Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content